432 related articles for article (PubMed ID: 16339698)
1. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in Iranian adolescents and young adults with beta-thalassemia major.
Shamshirsaz AA; Bekheirnia MR; Kamgar M; Pakbaz Z; Tabatabaie SM; Bouzari N; Pourzahedgilani N; Azarkeivan A; Hashemi SR; Moosavi F; Alebouyeh M; Vosough P; Kimiagar M; Shamshirsaz AA; Moradi M; Habibzadeh MR; Nobakhthaghighi N; Larijani B
Pediatr Hematol Oncol; 2007; 24(7):469-79. PubMed ID: 17786783
[TBL] [Abstract][Full Text] [Related]
3. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.
Baldini M; Forti S; Marcon A; Ulivieri FM; Orsatti A; Tampieri B; Airaghi L; Zanaboni L; Cappellini MD
Ann Hematol; 2010 Dec; 89(12):1207-13. PubMed ID: 20582415
[TBL] [Abstract][Full Text] [Related]
4. Effects of thalassemia major on bone mineral density in late adolescence.
Benigno V; Bertelloni S; Baroncelli GI; Bertacca L; Di Peri S; Cuccia L; Borsellino Z; Maggio MC
J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():337-42. PubMed ID: 12729413
[TBL] [Abstract][Full Text] [Related]
5. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
7. Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in beta-thalassemia major patients.
Wang CH; Wu KH; Tsai FJ; Peng CT; Tsai CH
Hemoglobin; 2006; 30(2):257-62. PubMed ID: 16798651
[TBL] [Abstract][Full Text] [Related]
8. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
[TBL] [Abstract][Full Text] [Related]
9. The relationship between lean body mass and bone mineral content in paediatric health and disease.
Crabtree NJ; Kibirige MS; Fordham JN; Banks LM; Muntoni F; Chinn D; Boivin CM; Shaw NJ
Bone; 2004 Oct; 35(4):965-72. PubMed ID: 15454104
[TBL] [Abstract][Full Text] [Related]
10. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
11. Osteopenia and vitamin D deficiency in children with sickle cell disease.
Chapelon E; Garabedian M; Brousse V; Souberbielle JC; Bresson JL; de Montalembert M
Eur J Haematol; 2009 Dec; 83(6):572-8. PubMed ID: 19682065
[TBL] [Abstract][Full Text] [Related]
12. The impact of genotype on endocrine complications in thalassaemia major.
Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
14. [Growth and endocrine function in major thalassemia].
Pérignon F; Brauner R; Souberbielle JC; de Montalembert M; Girot R
Arch Fr Pediatr; 1993 Oct; 50(8):657-63. PubMed ID: 8002739
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of reduced bone mass in children and adults with spastic quadriplegia.
King W; Levin R; Schmidt R; Oestreich A; Heubi JE
Dev Med Child Neurol; 2003 Jan; 45(1):12-6. PubMed ID: 12549750
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis in beta-thalassemia: Clinical and genetic aspects.
Origa R; Fiumana E; Gamberini MR; Armari S; Mottes M; Sangalli A; Paglietti E; Galanello R; Borgna-Pignatti C
Ann N Y Acad Sci; 2005; 1054():451-6. PubMed ID: 16339696
[TBL] [Abstract][Full Text] [Related]
17. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
18. Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia.
Vogiatzi MG; Autio KA; Schneider R; Giardina PJ
J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1415-21. PubMed ID: 15526720
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
Górska A; Urban M; Konstantynowicz J; Bartnicka M; Chlabicz S; Górski S; Kaczmarski M
Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and vitamin D receptor polymorphism in beta-thalassemia major.
El-Edel RH; Ghonaim MM; Abo-Salem OM; El-Nemr FM
Pak J Pharm Sci; 2010 Jan; 23(1):89-96. PubMed ID: 20067873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
